NO20023737D0 - Methods and Preparations for the Treatment of Inflammatory Disorder - Google Patents

Methods and Preparations for the Treatment of Inflammatory Disorder

Info

Publication number
NO20023737D0
NO20023737D0 NO20023737A NO20023737A NO20023737D0 NO 20023737 D0 NO20023737 D0 NO 20023737D0 NO 20023737 A NO20023737 A NO 20023737A NO 20023737 A NO20023737 A NO 20023737A NO 20023737 D0 NO20023737 D0 NO 20023737D0
Authority
NO
Norway
Prior art keywords
preparations
treatment
methods
inflammatory disorder
disorder
Prior art date
Application number
NO20023737A
Other languages
Norwegian (no)
Other versions
NO20023737L (en
Inventor
Elizabeth Keating
James M Kanagy
Original Assignee
Smithkline Beecham Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Co filed Critical Smithkline Beecham Co
Publication of NO20023737D0 publication Critical patent/NO20023737D0/en
Publication of NO20023737L publication Critical patent/NO20023737L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20023737A 2000-02-08 2002-08-07 Methods and Preparations for the Treatment of Inflammatory Disorder NO20023737L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (2)

Publication Number Publication Date
NO20023737D0 true NO20023737D0 (en) 2002-08-07
NO20023737L NO20023737L (en) 2002-09-27

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023737A NO20023737L (en) 2000-02-08 2002-08-07 Methods and Preparations for the Treatment of Inflammatory Disorder

Country Status (16)

Country Link
EP (1) EP1253919A4 (en)
JP (1) JP2003522142A (en)
KR (1) KR20020073577A (en)
CN (1) CN1398181A (en)
AU (1) AU7205701A (en)
BR (1) BR0108087A (en)
CA (1) CA2398184A1 (en)
CZ (1) CZ20022682A3 (en)
HK (1) HK1051319A1 (en)
HU (1) HUP0300689A3 (en)
IL (1) IL150963A0 (en)
MX (1) MXPA02007688A (en)
NO (1) NO20023737L (en)
PL (1) PL356447A1 (en)
WO (1) WO2001058441A1 (en)
ZA (1) ZA200206252B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) * 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
MXPA04002562A (en) * 2001-09-19 2004-05-31 Altana Pharma Ag Combination.
WO2003037349A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gmbh Type 4 phosphodiesterase inhibitors and uses thereof
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
WO2010097334A1 (en) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Drug combinations containing pde4 inhibitors and nsaids
WO2010097332A1 (en) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Drug combinations containing pde4 inhibitors and nsaids
SG186989A1 (en) 2010-07-14 2013-02-28 Novartis Ag Ip receptor agonist heterocyclic compounds
CN104053659B (en) 2012-01-13 2016-11-09 诺华股份有限公司 For treating the pyroles condensed as IP receptor stimulating agent of pulmonary hypertension (PAH) and associated conditions
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
SK279958B6 (en) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Compounds exhibiting anti-allergic and anti-inflammatory properties, pharmaceutical composition them containing and their use
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (en) * 1996-09-20 1998-10-30 NOVEL N-SUBSTITUTED CYCLIC AMINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
EP1253919A4 (en) 2007-03-14
HUP0300689A2 (en) 2003-07-28
PL356447A1 (en) 2004-06-28
CZ20022682A3 (en) 2003-09-17
WO2001058441A1 (en) 2001-08-16
HUP0300689A3 (en) 2003-09-29
NO20023737L (en) 2002-09-27
HK1051319A1 (en) 2003-08-01
ZA200206252B (en) 2003-08-26
CA2398184A1 (en) 2001-08-16
MXPA02007688A (en) 2002-12-13
KR20020073577A (en) 2002-09-27
BR0108087A (en) 2002-10-29
EP1253919A1 (en) 2002-11-06
IL150963A0 (en) 2003-02-12
AU7205701A (en) 2001-08-20
CN1398181A (en) 2003-02-19
JP2003522142A (en) 2003-07-22

Similar Documents

Publication Publication Date Title
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
NO20011964D0 (en) Well treatment fluids and methods using them
NO20033387L (en) Modified antibodies and methods of use
NO20014560D0 (en) Quinasolines and their therapeutic use
NO20024610L (en) Synergistic methods and compositions for the treatment of cancer
NO20030397L (en) Amyloid targeting imaging agents and uses of the same
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO20014314L (en) Compositions and methods for the treatment of staphylococcal infection
NO20033854D0 (en) N-but-3-enyl-norbuprenorphine and methods of use
NO20015516L (en) Preparations and uses of ET743 for the treatment of cancer
NO20012963L (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
NO20041214L (en) Substituted benzimidazole compounds and their use in the treatment of cancer
IS6966A (en) Cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
NO20014648D0 (en) Compounds and methods for the treatment of asthma, allergies and inflammatory diseases
DK1381382T3 (en) Methods and Preparations for the Treatment of Eye Diseases
NO20015772L (en) Compounds and methods for the treatment of post-traumatic stress syndrome
NO20033506D0 (en) Parasite-killing preparations and methods of use
NO20023737D0 (en) Methods and Preparations for the Treatment of Inflammatory Disorder
NO20010464L (en) Methods and Preparations for the Treatment of Gastroesophageal Reflux Syndrome
NO20023678L (en) Treatment of allergic and inflammatory conditions
DK1667693T3 (en) Preparations and Methods for the Use of Lamellar Bodies for Therapeutic Purposes
PL366009A1 (en) Methods and compositions for the treatment of inflammatory diseases
PT1178981E (en) SUBSTITUTED 3-PYRIDYL-4-ARYLIPYROLS AND THERAPEUTIC AND PROFILACTIC METHODS
IS6707A (en) Preparation for the prevention and treatment of cancer
DK0981349T3 (en) 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumors and CNS diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application